Long-term Follow Up of the Stability 1 Trial
Launched by WESTERN UNIVERSITY, CANADA · Mar 13, 2025
Trial Information
Current as of May 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • ACL deficient knee
- • skeletally mature to 25 years of age
- * 2 or more of:
- • competitive pivoting sport
- • grade 2 pivot shift or greater
- • generalized ligament laxity - Beighton score of 4 or greater
- Exclusion criteria:
- • previous ACL reconstruction on either knee
- • multi-ligament injury (two or more ligaments requiring surgical attention)
- • symptomatic articular cartilage defect requiring treatment other than debridement
- • greater than 3 degrees of asymmetric varus
- • unable to complete outcome questionnaires
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Hamilton, Ontario, Canada
London, Ontario, Canada
Winnipeg, Manitoba, Canada
Banff, Alberta, Canada
Coventry, , United Kingdom
New Westminster, British Columbia, Canada
Kingston, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported